查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1301163

医疗保健合同研究所市场规模、份额和趋势分析报告：按类型、按服务、按地区、细分趋势：2023-2030

Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, Clinical), By Services (Clinical Monitoring, Data Management), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 175 Pages | 商品交期: 2-10个工作天内

价格

医疗保健合同研究机构市场增长和趋势

Grand View Research, Inc.的最新报告显示，到 2030 年，全球医疗保健合同研究组织市场规模预计将达到 805 亿美元，2023 年至 2030 年復合年增长率为 7.8%。

预计药物开发成本的增加将在预测期内推动市场需求。不断上升的临床试验成本和患者招募挑战也促使生物製药公司将目光投向中欧和东欧、亚太地区、拉丁美洲和中东等地区，以降低成本并加快患者招募。

此外，行业参与者在紧迫的时间安排上面临的压力越来越大，这增加了将研究活动外包给 CRO 的需求。一些政府机构还外包临床试验活动，以便利用必要的基础设施和专业知识进行临床试验，并最大限度地减少成本和时间表。

受疫情影响，临床试验中心关闭，CRO市场暂时受到影响。然而，由于对治疗的需求量很大，临床试验中心已经重新开放，但需要采取一定的措施和预防措施，以避免病毒传播。此外，全球对冠状病毒疫苗的关注对 COVID-19 疫苗和药物的开发产生了重大影响。预计这将对市场产生积极影响。

过去五年，併购交易数量大幅增加。从2016年到2023年，我们见证了多起大型併购。此外，大型交易的趋势将在 2021 年及以后回升，例如 M&B Sciences Inc. 于 2022 年 3 月收购 Clara Health，扩大了 M&B Sciences 基于数字技术的临床试验的范围。此外，2021年12月，Thermo Fisher宣布收购製药服务巨头PPD，2021年2月，ICON plc宣布收购PRA Health Sciences。生物製药服务领域使用的分析技术和软件解决方案已经进入整合时代。因此，上述因素支撑了市场的增长。

医疗保健合同研究所市场报告亮点

  • 从类型来看，临床细分市场将在2022年主导全球医疗保健CRO市场，占据最大份额，达到76.2%。因为临床领域由四个涉及主题的复杂阶段组成。对新疗法的强劲需求进一步促进了该领域的增长。
  • 在服务中，临床监测领域在 2022 年拥有最大的市场份额，达到 20.2%。
  • 由于多家全球公司将大部分收入投资于研究活动，北美在 2022 年占据了 24.8% 的巨大市场份额。
  • 由于与西方国家相比成本较低，预计亚太地区在预测期内将增长 9.5%。
  • 由于该疾病的高患病率，预计中国、日本和印度的合同研究组织市场将出现显着增长。

目录

第一章 调查方法和范围

  • 市场细分和范围
    • 段定义
    • 类型
    • 服务
  • 区域范围
  • 估计/预测时间表
  • 目的
    • 目标1
    • 目标2
    • 目标 3
  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查
  • 信息或数据分析
    • 数据分析模型
  • 市场形成和验证
  • 型号详情
    • 产品流向分析
    • 母市场分析
  • 二级信息列表
  • 缩略语表

第二章执行摘要

  • 市场展望
  • 分部展望
  • 竞争考虑

3.医疗保健合同研究组织市场变量、趋势和范围

  • 市场谱系展望
    • 母公司市场展望
    • 相关/补充市场展望
  • 市场动态
    • 市场驱动力分析
    • 市场约束因素分析
  • 医疗保健合同研究所市场分析工具
    • 行业分析 - 搬运工
    • PESTEL 分析
    • COVID-19 的影响分析

第四章医疗合同研究机构市场：按类型估计和趋势分析

  • 医疗保健合同研究组织市场，按类型：细分仪表板
  • 医疗保健合同研究组织市场，按类型：变化分析
    • 药物发现
    • 临床前
    • 临床

第五章医疗合同研究机构市场：按服务分类的估计和趋势分析

  • 医疗保健合同研究组织市场，按服务：细分仪表板
  • 医疗保健合同研究组织市场，按服务分类：变化分析
    • 项目管理/临床供应管理
    • 数据管理
    • 监管/医疗
    • 医学写作
    • 临床监测
    • 质量控制/保证
    • 生物统计学
    • 支付给调查员的费用
    • 实验室
    • 患者和设施招募
    • 技术
    • 其他

第六章 医疗合同研究机构市场：按地区估算及趋势分析

  • 2022 年和 2030 年区域市场份额分析
  • 区域市场仪表板
  • 全球区域市场快照
  • 北美
    • 2018-2030 年市场估算和预测（收入，百万美元）
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 瑞士
    • 比利时
    • 荷兰
    • 奥地利
  • 亚太地区
    • 日本
    • 印度
    • 中国
    • 韩国
    • 澳大利亚
    • 泰国
    • 台湾
    • 印度尼西亚
    • 马来西亚
    • 新加坡
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 智利
  • 中东和北非
    • 埃及
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 伊朗
    • 以色列
  • 世界其他地区
    • 南非

第7章 竞争格局

  • 市场进入者分类
    • 创新者
    • 市场领导者
    • 启动
    • 2022 年公司市场份额分析
  • 公司简介
    • ICON Plc
    • Charles River Laboratories
    • Syneos Health
    • IQVIA Inc
    • GVK Biosciences Private Limited
    • Laboratory Corporation of America Holdings
    • Thermo Fisher Scientific Inc.
    • Parexel International Corporation
    • Medidata Solutions, Inc
    • Pharmaron GMBH.
    • SGS SA
    • KCR SA
    • CTI Clinical Trial &Consulting
    • PSI
    • Worldwide Clinical Trials
    • Wuxi AppTec
    • Advanced Clinical
    • Caidya
Product Code: 978-1-68038-688-2

Healthcare Contract Research Organization Market Growth & Trends

The global healthcare contract research organization market size is expected to reach USD 80.5 billion by 2030 and is projected to expand at a CAGR of 7.8% from 2023 to 2030, according to a new report by Grand View Research, Inc. The increasing cost of drug development is expected to drive market demand over the forecast period. Also, rising clinical trials cost and challenges pertaining to patient recruitment have led biopharmaceutical companies to turn to regions like Central and Eastern Europe, Asia Pacific, Latin America, and the Middle East for cost savings and quick patient recruitment.

In addition, growing pressure on industry players to follow stringent timelines has increased the demand for outsourcing research activities to contract research organizations(CRO)s. Some government organizations are also outsourcing their clinical trial activities so that they can carry out clinical trials with the required infrastructure and expertise and minimize their cost and timelines.

The CRO market was temporarily affected by the ongoing pandemic, as it led to the closure of clinical trial sites. However, owing to the significant demand for treatments, the clinical trial sites were reopened with certain measures and precautions to avoid the spread of the virus. Moreover, the worldwide focus on finding a vaccine against coronavirus has had a significant impact on the development of vaccines & drugs for COVID-19. This is expected to have a positive impact on the market.

Over the past 5 years, the number of mergers and acquisitions significantly increased. Several large mergers have been witnessed since 2016 till 2023. Moreover, the trend of large transactions seems to be picking up since 2021, as in March 2022, M&B Sciences Inc, acquired Clara Health, which expanded M&B Sciences' access to digital technology-based clinical trials. Moreover, in December 2021, Thermo Fisher announced the acquisition of pharmaceutical services giant PPD, and in February 2021, ICON plc announced the acquisition of PRA Health Sciences. An era of consolidation has been witnessed around analytical technologies and software solutions used in the biopharmaceutical and pharmaceutical companies' services space. Hence, the aforementioned factors supported the market's growth.

Healthcare Contract Research Organization Market Report Highlights

  • Based on type, the clinical segment has dominated the global healthcare CRO market in 2022, with the largest share of 76.2% owing to the fact that it comprises four elaborate phases, including human subjects. The significant demand for new treatments has further contributed to the growth of the segment
  • Among services, the clinical monitoring segment was the largest in terms of market share at 20.2% in 2022
  • North America held a significant market share of 24.8% in 2022 due to the presence of several global players who invest a major part of their revenue in research activities
  • Asia Pacific is anticipated to witness lucrative growth of 9.5% over the forecast period due to the reduced cost it offers in comparison to the western economies
  • China, Japan, and India are projected to witness tremendous growth in the contract research organization market owing to high disease prevalence

Table of content

Chapter 1. Methodology And Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment Definitions
    • 1.1.2. Type
    • 1.1.3. Service
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective-1
    • 1.4.2. Objective-2
    • 1.4.3. Objective-3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
    • 1.9.2. Parent Market Analysis
  • 1.10. List Of Secondary Sources
  • 1.11. List Of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Healthcare Contract Research Organization Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Rate of Clinical Research To Boost Demand For Outsourcing Services
      • 3.2.1.2. Increasing Adoption Of Advanced Technologies
      • 3.2.1.3. Increasing Mergers and Collaborations
      • 3.2.1.4. Increasing Demand For Outsourcing Services Across The Developing Economies
      • 3.2.1.5. Patent Cliff
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Quality issues of CRO services
      • 3.2.2.2. Intellectual property rights issues
  • 3.3. Healthcare Contract Research Organization Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat Of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Healthcare Contract Research Organization Market: Type Estimates & Trend Analysis

  • 4.1. Healthcare Contract Research Organization Market, By Type: Segment Dashboard
  • 4.2. Healthcare Contract Research Organization Market, By Type: Movement Analysis
  • 4.3. Healthcare Contract Research Organization Market Estimates & Forecasts, By Type, 2018 - 2030
    • 4.3.1. Drug Discovery
      • 4.3.1.1. Drug Discovery Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
      • 4.3.1.2. Target Validation
      • 4.3.1.2.1. Target Validation Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
      • 4.3.1.3. Lead Identification
      • 4.3.1.3.1. Lead Identification Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
      • 4.3.1.4. Lead Optimization
      • 4.3.1.4.1. Lead Optimization Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 4.3.2. Pre-clinical
      • 4.3.2.1. Pre-clinical Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 4.3.3. Clinical
      • 4.3.3.1. Clinical Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
      • 4.3.3.2. Phase I Trial Services
      • 4.3.3.2.1. Phase I Trial Services Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
      • 4.3.3.3. Phase II Trial Services
      • 4.3.3.3.1. Phase II Trial Services Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
      • 4.3.3.4. Phase III Trial Services
      • 4.3.3.4.1. Phase III Trial Services Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
      • 4.3.3.5. Phase IV Trial Services
      • 4.3.3.5.1. Phase IV Trial Services Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)

Chapter 5. Healthcare Contract Research Organization Market: Services Estimates & Trend Analysis

  • 5.1. Healthcare Contract Research Organization Market, By Services: Segment Dashboard
  • 5.2. Healthcare Contract Research Organization Market, By Services: Movement Analysis
  • 5.3. Healthcare Contract Research Organization Market Estimates & Forecasts, By Services, 2018 - 2030
    • 5.3.1. Project Management/Clinical Supply Management
      • 5.3.1.1. Project Management/Clinical Supply Management Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 5.3.2. Data Management
      • 5.3.2.1. Data Management Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 5.3.3. Regulatory/Medical Affairs
      • 5.3.3.1. Regulatory/Medical Affairs Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 5.3.4. Medical Writing
      • 5.3.4.1. Medical Writing Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 5.3.5. Clinical Monitoring
      • 5.3.5.1. Clinical Monitoring Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 5.3.6. Quality Management/Assurance
      • 5.3.6.1. Quality Management/Assurance Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 5.3.7. Bio-statistics
      • 5.3.7.1. Bio-statistics Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 5.3.8. Investigator Payments
      • 5.3.8.1. Investigator Payments Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 5.3.9. Laboratory
      • 5.3.9.1. Laboratory Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 5.3.10. Patient and Site Recruitment
      • 5.3.10.1. Patient and Site Recruitment Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 5.3.11. Technology
      • 5.3.11.1. Technology Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
    • 5.3.12. Others
      • 5.3.12.1. Others Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)

Chapter 6. Healthcare Contract Research Organization Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2022 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. North America
    • 6.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
  • 6.5. Europe
    • 6.5.1. UK
      • 6.5.1.1. Key Country Dynamics
      • 6.5.1.2. Competitive Scenario
      • 6.5.1.3. Regulatory Framework
      • 6.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
    • 6.5.2. Germany
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
    • 6.5.3. France
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
    • 6.5.4. Italy
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
    • 6.5.5. Spain
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
    • 6.5.6. Switzerland
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Switzerland Market Estimates and Forecasts, 2018 - 2030
    • 6.5.7. Belgium
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Belgium Market Estimates and Forecasts, 2018 - 2030
    • 6.5.8. Netherlands
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Competitive Scenario
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Netherlands Market Estimates and Forecasts, 2018 - 2030
    • 6.5.9. Austria
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Competitive Scenario
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Austria Market Estimates and Forecasts, 2018 - 2030
  • 6.6. Asia Pacific
    • 6.6.1. Japan
      • 6.6.1.1. Key Country Dynamics
      • 6.6.1.2. Competitive Scenario
      • 6.6.1.3. Regulatory Framework
      • 6.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
    • 6.6.2. India
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. India Market Estimates and Forecasts, 2018 - 2030
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
    • 6.6.4. South Korea
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
    • 6.6.6. Thailand
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
    • 6.6.7. Taiwan
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Taiwan Market Estimates and Forecasts, 2018 - 2030
    • 6.6.8. Indonesia
      • 6.6.8.1. Key Country Dynamics
      • 6.6.8.2. Competitive Scenario
      • 6.6.8.3. Regulatory Framework
      • 6.6.8.4. Indonesia Market Estimates and Forecasts, 2018 - 2030
    • 6.6.9. Malaysia
      • 6.6.9.1. Key Country Dynamics
      • 6.6.9.2. Competitive Scenario
      • 6.6.9.3. Regulatory Framework
      • 6.6.9.4. Malaysia Market Estimates and Forecasts, 2018 - 2030
    • 6.6.10. Singapore
      • 6.6.10.1. Key Country Dynamics
      • 6.6.10.2. Competitive Scenario
      • 6.6.10.3. Regulatory Framework
      • 6.6.10.4. Singapore Market Estimates and Forecasts, 2018 - 2030
  • 6.7. Latin America
    • 6.7.1. Brazil
      • 6.7.1.1. Key Country Dynamics
      • 6.7.1.2. Competitive Scenario
      • 6.7.1.3. Regulatory Framework
      • 6.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
    • 6.7.2. Mexico
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Mexico Market Estimates and Forecasts, 2018 - 2030
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
    • 6.7.4. Colombia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Colombia Market Estimates and Forecasts, 2018 - 2030
    • 6.7.5. Chile
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Chile Market Estimates and Forecasts, 2018 - 2030
  • 6.8. Middle East & North Africa
    • 6.8.1. Egypt
      • 6.8.1.1. Key Country Dynamics
      • 6.8.1.2. Competitive Scenario
      • 6.8.1.3. Regulatory Framework
      • 6.8.1.4. Egypt Market Estimates and Forecasts, 2018 - 2030
    • 6.8.2. Saudi Arabia
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
    • 6.8.3. UAE
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
    • 6.8.4. Iran
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Iran Market Estimates and Forecasts, 2018 - 2030
    • 6.8.5. Israel
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Competitive Scenario
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Israel Market Estimates and Forecasts, 2018 - 2030
  • 6.9. Rest of the World
    • 6.9.1. South Africa
      • 6.9.1.1. Key Country Dynamics
      • 6.9.1.2. Competitive Scenario
      • 6.9.1.3. Regulatory Framework
      • 6.9.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
    • 7.1.1. Innovators
    • 7.1.2. Market Leaders
    • 7.1.3. Emerging Players
    • 7.1.4. Company Market Share Analysis, 2022
  • 7.2. Company Profiles
    • 7.2.1. ICON Plc
      • 7.2.1.1. Company Overview
      • 7.2.1.2. Financial Performance
      • 7.2.1.3. Service Benchmarking
      • 7.2.1.4. Strategic Initiatives
    • 7.2.2. Charles River Laboratories
      • 7.2.2.1. Company Overview
      • 7.2.2.2. Financial Performance
      • 7.2.2.3. Service Benchmarking
      • 7.2.2.4. Strategic Initiatives
    • 7.2.3. Syneos Health
      • 7.2.3.1. Company Overview
      • 7.2.3.2. Financial Performance
      • 7.2.3.3. Service Benchmarking
      • 7.2.3.4. Strategic Initiatives
    • 7.2.4. IQVIA Inc
      • 7.2.4.1. Company Overview
      • 7.2.4.2. Financial Performance
      • 7.2.4.3. Service Benchmarking
      • 7.2.4.4. Strategic Initiatives
    • 7.2.5. GVK Biosciences Private Limited
      • 7.2.5.1. Company Overview
      • 7.2.5.2. Financial Performance
      • 7.2.5.3. Service Benchmarking
      • 7.2.5.4. Strategic Initiatives
    • 7.2.6. Laboratory Corporation of America Holdings
      • 7.2.6.1. Company Overview
      • 7.2.6.2. Financial Performance
      • 7.2.6.3. Service Benchmarking
      • 7.2.6.4. Strategic Initiatives
    • 7.2.7. Thermo Fisher Scientific Inc.
      • 7.2.7.1. Company Overview
      • 7.2.7.2. Financial Performance
      • 7.2.7.3. Service Benchmarking
      • 7.2.7.4. Strategic Initiatives
    • 7.2.8. Parexel International Corporation
      • 7.2.8.1. Company Overview
      • 7.2.8.2. Financial Performance
      • 7.2.8.3. Service Benchmarking
      • 7.2.8.4. Strategic Initiatives
    • 7.2.9. Medidata Solutions, Inc
      • 7.2.9.1. Company Overview
      • 7.2.9.2. Financial Performance
      • 7.2.9.3. Service Benchmarking
      • 7.2.9.4. Strategic Initiatives
    • 7.2.10. Pharmaron GMBH.
      • 7.2.10.1. Company Overview
      • 7.2.10.2. Financial Performance
      • 7.2.10.3. Service Benchmarking
      • 7.2.10.4. Strategic Initiatives
    • 7.2.11. SGS SA
      • 7.2.11.1. Company Overview
      • 7.2.11.2. Financial Performance
      • 7.2.11.3. Service Benchmarking
      • 7.2.11.4. Strategic Initiatives
    • 7.2.12. KCR S.A.
      • 7.2.12.1. Company Overview
      • 7.2.12.2. Financial Performance
      • 7.2.12.3. Service Benchmarking
      • 7.2.12.4. Strategic Initiatives
    • 7.2.13. CTI Clinical Trial & Consulting
      • 7.2.13.1. Company Overview
      • 7.2.13.2. Financial Performance
      • 7.2.13.3. Service Benchmarking
      • 7.2.13.4. Strategic Initiatives
    • 7.2.14. PSI
      • 7.2.14.1. Company Overview
      • 7.2.14.2. Financial Performance
      • 7.2.14.3. Service Benchmarking
      • 7.2.14.4. Strategic Initiatives
    • 7.2.15. Worldwide Clinical Trials
      • 7.2.15.1. Company Overview
      • 7.2.15.2. Financial Performance
      • 7.2.15.3. Service Benchmarking
      • 7.2.15.4. Strategic Initiatives
    • 7.2.16. Wuxi AppTec
      • 7.2.16.1. Company Overview
      • 7.2.16.2. Financial Performance
      • 7.2.16.3. Service Benchmarking
      • 7.2.16.4. Strategic Initiatives
    • 7.2.17. Advanced Clinical
      • 7.2.17.1. Company Overview
      • 7.2.17.2. Financial Performance
      • 7.2.17.3. Service Benchmarking
      • 7.2.17.4. Strategic Initiatives
    • 7.2.18. Caidya
      • 7.2.18.1. Company Overview
      • 7.2.18.2. Financial Performance
      • 7.2.18.3. Service Benchmarking
      • 7.2.18.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Healthcare Contract Research Outsourcing Market, by Region, 2018 - 2030 (USD Million)
  • Table 4 Global Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 5 Global Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 6 Global Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 7 Global Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 8 North America Healthcare Contract Research Outsourcing Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 10 North America Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 11 North America Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 12 North America Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 13 U.S. Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 14 U.S. Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 15 U.S. Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 16 U.S. Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 17 Canada Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 19 Canada Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 20 Canada Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 21 Europe Healthcare Contract Research Outsourcing Market, by Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 23 Europe Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 24 Europe Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 25 Europe Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 26 UK Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 UK Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 28 UK Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 29 UK Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 30 Germany Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 Germany Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 32 Germany Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 33 Germany Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 34 France Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 35 France Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 36 France Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 37 France Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 38 Italy Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 39 Italy Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 40 Italy Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 41 Italy Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 42 Spain Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 43 Spain Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 44 Spain Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 45 Spain Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 46 Switzerland Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 47 Switzerland Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 48 Switzerland Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 49 Switzerland Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 50 Belgium Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 51 Belgium Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 52 Belgium Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 53 Belgium Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 54 Netherlands Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 55 Netherlands Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 56 Netherlands Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 57 Netherlands Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 58 Austria Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 59 Austria Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 60 Austria Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 61 Austria Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Healthcare Contract Research Outsourcing Market, by Country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 67 India Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 68 India Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 69 India Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 70 India Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 71 China Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 72 China Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 73 China Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 74 China Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 75 Japan Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 76 Japan Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 77 Japan Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 78 Japan Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 79 South Korea Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 80 South Korea Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 81 South Korea Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 82 South Korea Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 83 Taiwan Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 84 Taiwan Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 85 Taiwan Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 86 Taiwan Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 87 Australia Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 88 Australia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 89 Australia Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 90 Australia Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 91 Indonesia Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 92 Indonesia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 93 Indonesia Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 94 Indonesia Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 95 Malaysia Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 96 Malaysia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 97 Malaysia Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 98 Malaysia Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 99 Singapore Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 100 Singapore Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 101 Singapore Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 102 Singapore Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 103 Thailand Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 104 Thailand Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 105 Thailand Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 106 Thailand Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 107 Latin America Healthcare Contract Research Outsourcing Market, by Country, 2018 - 2030 (USD Million)
  • Table 108 Latin America Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 109 Latin America Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 110 Latin America Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 111 Latin America Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 112 Brazil Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 113 Brazil Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 114 Brazil Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 115 Brazil Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 116 Mexico Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 117 Mexico Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 118 Mexico Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 119 Mexico Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 120 Argentina Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 121 Argentina Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 122 Argentina Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 123 Argentina Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 124 Colombia Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 125 Colombia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 126 Colombia Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 127 Colombia Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 128 Chile Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 129 Chile Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 130 Chile Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 131 Chile Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 132 MEA Healthcare Contract Research Outsourcing Market, by Country, 2018 - 2030 (USD Million)
  • Table 133 MEA Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 134 MEA Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 135 MEA Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 136 MEA Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 137 Egypt Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 138 Egypt Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 139 Egypt Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 140 Egypt Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 144 Saudi Arabia Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 145 UAE Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 146 UAE Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 147 UAE Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 148 UAE Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 149 Iran Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 150 Iran Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 151 Iran Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 152 Iran Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 153 Israel Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 154 Israel Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 155 Israel Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 156 Rest Of The World Healthcare Contract Research Outsourcing Market, by Country, 2018 - 2030 (USD Million)
  • Table 157 Rest Of The World Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 158 Rest Of The World Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 159 Rest Of The World Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 160 Rest Of The World Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 161 South Africa Healthcare Contract Research Outsourcing Market, by Type, 2018 - 2030 (USD Million)
  • Table 162 South Africa Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018 - 2030 (USD Million)
  • Table 163 South Africa Healthcare Contract Research Outsourcing Market, by Clinical, 2018 - 2030 (USD Million)
  • Table 164 South Africa Healthcare Contract Research Outsourcing Market, by Service, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity Flow Analysis
  • Fig. 9 Parent Market Analysis
  • Fig. 10 Healthcare CRO market snapshot (2022)
  • Fig. 11 Market trends and outlook
  • Fig. 12 Healthcare CRO market segmentation
  • Fig. 13 Market driver relevance analysis (Current & future impact)
  • Fig. 14 Benefits of using robotic labs
  • Fig. 15 Pharmaceutical R&D spending 2020 - 2022 (USD Billion)
  • Fig. 16 Market restraint relevance analysis (Current & future impact)
  • Fig. 17 Penetration & growth prospect mapping
  • Fig. 18 Porter's five forces analysis
  • Fig. 19 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 20 Healthcare CRO market stage outlook: Segment dashboard
  • Fig. 21 Healthcare CRO market: Type movement analysis
  • Fig. 22 Drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 23 Target validation market, 2018 - 2030 (USD Million)
  • Fig. 24 Lead identification market, 2018 - 2030 (USD Million)
  • Fig. 25 Lead optimization market, 2018 - 2030 (USD Million)
  • Fig. 26 Pre-clinical market, 2018 - 2030 (USD Million)
  • Fig. 27 Clinical market, 2018 - 2030 (USD Million)
  • Fig. 28 Phase I trial services market, 2018 - 2030 (USD Million)
  • Fig. 29 Phase II trial services market, 2018 - 2030 (USD Million)
  • Fig. 30 Phase III trial services market, 2018 - 2030 (USD Million)
  • Fig. 31 Phase IV trial services market, 2018 - 2030 (USD Million)
  • Fig. 32 Healthcare CRO market Service outlook: Segment dashboard
  • Fig. 33 Healthcare CRO market: Service movement analysis
  • Fig. 34 Parameters for measuring success of provider solution
  • Fig. 35 Project management/clinical supply management market, 2018 - 2030 (USD Million)
  • Fig. 36 Clinical data management flow
  • Fig. 37 Data management market, 2018 - 2030 (USD Million)
  • Fig. 38 Regulatory/medical affairs market, 2018 - 2030 (USD Million)
  • Fig. 39 Medical writing market, 2018 - 2030 (USD Million)
  • Fig. 40 Clinical monitoring market, 2018 - 2030 (USD Million)
  • Fig. 41 Quality management/ assurance market, 2018 - 2030 (USD Million)
  • Fig. 42 Bio-statistics market, 2018 - 2030 (USD Million)
  • Fig. 43 Investigator payments market, 2018 - 2030 (USD Million)
  • Fig. 44 Laboratory market, 2018 - 2030 (USD Million)
  • Fig. 45 Strategic initiatives with positive impact on patient recruitment
  • Fig. 46 Patient and site recruitment market, 2018 - 2030 (USD Million)
  • Fig. 47 Technology services market, 2018 - 2030 (USD Million)
  • Fig. 48 Other services market, 2018 - 2030 (USD Million)
  • Fig. 49 Regional market: Key takeaways
  • Fig. 50 Regional outlook, 2022 & 2030
  • Fig. 51 North America market, 2018 - 2030 (USD Million)
  • Fig. 52 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 53 Canada market, 2018 - 2030 (USD Million)
  • Fig. 54 Europe market, 2018 - 2030 (USD Million)
  • Fig. 55 UK market, 2018 - 2030 (USD Million)
  • Fig. 56 Germany market, 2018 - 2030 (USD Million)
  • Fig. 57 France market, 2018 - 2030 (USD Million)
  • Fig. 58 Italy market, 2018 - 2030 (USD Million)
  • Fig. 59 Spain market, 2018 - 2030 (USD Million)
  • Fig. 60 Switzerland market, 2018 - 2030 (USD Million)
  • Fig. 61 Belgium market, 2018 - 2030 (USD Million)
  • Fig. 62 Netherlands market, 2018 - 2030 (USD Million)
  • Fig. 63 Austria market, 2018 - 2030 (USD Million)
  • Fig. 64 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 65 India market, 2018 - 2030 (USD Million)
  • Fig. 66 China market, 2018 - 2030 (USD Million)
  • Fig. 67 Japan market, 2018 - 2030 (USD Million)
  • Fig. 68 South Korea market, 2018 - 2030 (USD Million)
  • Fig. 69 Taiwan market, 2018 - 2030 (USD Million)
  • Fig. 70 Australia market, 2018 - 2030 (USD Million)
  • Fig. 71 Indonesia market, 2018 - 2030 (USD Million)
  • Fig. 72 Malaysia market, 2018 - 2030 (USD Million)
  • Fig. 73 Singapore market, 2018 - 2030 (USD Million)
  • Fig. 74 Thailand market, 2018 - 2030 (USD Million)
  • Fig. 75 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 76 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 77 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 78 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 79 Colombia market, 2018 - 2030 (USD Million)
  • Fig. 80 Chile market, 2018 - 2030 (USD Million)
  • Fig. 81 Middle East & North Africa market, 2018 - 2030 (USD Million)
  • Fig. 82 Egypt market, 2018 - 2030 (USD Million)
  • Fig. 83 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 84 UAE market, 2018 - 2030 (USD Million)
  • Fig. 85 Iran market, 2018 - 2030 (USD Million)
  • Fig. 86 Israel market, 2018 - 2030 (USD Million)
  • Fig. 87 Rest of the World market, 2018 - 2030 (USD Million)
  • Fig. 88 South Africa market, 2018 - 2030 (USD Million)